Tim Shannon is a physician-turned-investor who trained as a pulmonary and critical care doctor before serving as CEO of publicly traded biotech company CuraGen and joining Canaan Partners. He served as founding CEO of Arvinas, helping to build one of the pioneering companies in targeted protein degradation, and frequently takes on board chair roles where he shapes scientific strategy and development plans rather than just providing capital. Tim Shannon is a physician-turned-investor who trained as a pulmonary and critical care doctor before serving as CEO of publicly traded biotech company CuraGen and joining Canaan Partners. He served as founding CEO of Arvinas, helping to build one of the pioneering companies in targeted protein degradation, and frequently takes on board chair roles where he shapes scientific strategy and development plans rather than just providing capital.